Navigation Links
Immunosuppressive Action Of Fungal Metabolite - Gliotoxin

Researchers from Japan have recently demonstrated the first evidence that mast cell is a direct target of gliotoxin.

Fungal secondary metabolites such as gliotoxin, an epipolythiodioxopiperazine toxin produced by pathogenic fungi like Candida and Aspergillus//, possess immunosuppressive activities and have been thought to contribute to pathology of fungal infections in animals and humans.

Mast cells play a key role in host defense and are important both for innate and adaptive immunity, and so, these findings suggest that suppression of mast cell activation might contribute to the establishment of infections for the pathogenic gliotoxin-producing fungi. Since recent studies show that mast cell plays a crucial role in the front of host defense, researchers examined whether fungal secondary metabolites affected mast cell activation.

Their study findings appear in the journal Clinical Immunology (available online 6 October 2005) The researchers found that gliotoxin had suppressive effects on mast cell activation, including degranulation, leukotriene C4 secretion, and TNF-á and IL-13 production. Gliotoxin also suppressed intracellular Ca2+ rise through store-operated Ca2+ channels with a minimal effect on depletion of internal Ca2+ stores.

Finally, gliotoxin induced intracellular production of superoxide possibly through a thiol redox cycling, which appeared to mediate suppressive effects on mast cell activation.
'"/>




Page: 1

Related medicine news :

1. Immunosuppressive drug shows promise in treatment of eye disorder
2. A Newly Identified Immunosuppressive Protein in Rheumatoid Arthritis
3. Action of nerve cells
4. Herbs With Estrogen Action Aggravate Cancer Risk
5. Legal Action against Authority Regarding Outbreak of Legionnaires’ Diseas
6. Mode Of Action Of The Anti-Convulsant Valproate
7. Action Plan Against Drug Deaths Launched
8. Ramadoss to Take Severe Action against Fertility Clinics Conducting Stem Cell Therapy
9. UN Formulates Action Plan for Relief to Recovery in Quake-hit Areas of Pakistan
10. HIV Infected Body Parts Stolen: Biomedical Tissue Services To Face Legal Action
11. India to Implement National Action Plan against TB-HIV
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2016)... IL (PRWEB) , ... February 06, 2016 , ... ... recovery phases of eating disorder treatment helps to reduce the frequency and level ... of the Recovery Phase: Re-Establishing Healthy Identity and Purpose,” will explore the critical ...
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment ... new clinical and scientific initiatives have all marked the last 12 months at ... and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined ...
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe ... signed a joint enrollment and degree completion agreement. The agreement, which begins ... degrees at FHU|Dickson. , The agreement allows students to be jointly admitted ...
(Date:2/5/2016)... ... ... The American public tends to feel uncomfortable about drinking recycled waste water ... well water. The recent experience with lead contaminated water in Flint, Michigan, according to ... increasing public acceptance of recycled waste water as drinking water. , The Flint ...
(Date:2/5/2016)... , ... February 05, 2016 , ... At its annual ... Patrick McDermott as Chairman of the National Board of Directors. Mr. McDermott succeeds former ... the Board,” stated Leslie A. Chambers , APDA President and CEO. “Pat has ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Summary Breast ... cancer and the most common cancer in women worldwide, ... disease exceedingly prevalent. The number of women diagnosed with ... but the number of deaths has declined due to ... treatment has been revolutionized in the past four decades, ...
(Date:2/4/2016)... Feb. 4, 2016 Mettler-Toledo International Inc. (NYSE: ... 2015.  Provided below are the highlights: , ... compared with the prior year.  Reported sales decreased 3% ... quarter. , Net earnings per diluted share as ... prior- year period.  Adjusted EPS was $4.65, an increase ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: